Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation
Clinical trial NCT01103310 · COMPLETED
Trial details
- NCT number
- NCT01103310
- Sponsor
- Lantheus Biosciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-08-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.